ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2015

Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters.

William R StrohlPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.